Whole-body distribution of three Pseudomonas phages characterized by a translational physiologically based pharmacokinetic model
Antimicrobial Agents and Chemotherapy · 2026
DOI: 10.1128/aac.01506-25 ↗Kurz gefasst
Fachartikel in der Zeitschrift Antimicrobial Agents and Chemotherapy, 2026. Verfasst von Arne Echterhof und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Infectious Diseases and Geographic Medicine, Department of Medicine, Stanford University School of Medicine, Stanford, California, USA. Hauptthemen laut MEDLINE: Pseudomonas aeruginosa, Pseudomonas Phages. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, National Institute of Allergy and Infectious Diseases, NHLBI NIH HHS.
Abstract (Originalsprache)
Bacteriophage (phage) therapy holds great promise for treating antimicrobial-resistant infections. However, the pharmacokinetics (PK) of phage have been difficult to characterize due to a lack of standardized protocols for phage purification, labeling, and in vivo quantification. Here, we present robust methods for ultrapure phage preparation, as well as non-destructive, highly stable attachment of radio-iodide to phage using a well-described Sulfo-SHPP linker. We purified and radiolabeled the phage strains, PAML-31-1, OMKO1, and Luz24, lytic to drug-resistant Pseudomonas aeruginosa, for biodistribution assay in normal young adult CD-1 mice injected via intravenous injection. Groups of five mice were euthanized, and tissues/organs were removed for weighing and scintillation well counting of 125 I activity. A physiologically based PK model was then constructed, focusing on compartments describing blood, lung, muscle, bone, liver, stomach, spleen, small intestines, large intestines, and kidney. Tissue partition coefficients (K P ) were estimated for high-perfusion organs (lung and kidney) as 0.000138, GI organs (liver, spleen, and stomach) as 0.627, and all other organs as 0.220. Monte Carlo simulations predicted rapid elimination of phage in humans, with blood concentrations being
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Infectious Diseases and Geographic Medicine, Department of Medicine, Stanford University School of Medicine, Stanford, California, USA.
- Institute of Medical Microbiology, University Hospital of Muenster, Muenster, Germany.
- Division of Clinical and Translational Therapeutics, School of Pharmacy & Pharmaceutical Sciences, University at Buffalo, Buffalo, New York, USA.
- Division of Pediatric Radiology and Nuclear Medicine, Department of Radiology, Lucile Packard Children's Hospital, Stanford, California, USA.
ORCID-Profile: Arne Echterhof, Tejas Dharmaraj, Patrick Blankenberg, Thomas D Nguyen, Paul L Bollyky, Nicholas M Smith, Francis G Blankenberg
Förderung
- NIAID NIH HHS
- National Institute of Allergy and Infectious Diseases
- NHLBI NIH HHS
- Stanford Bio-X
- Stanford Woods Institute for the Environment
- NIA NIH HHS
- NIBIB NIH HHS
- National Institute on Aging
Zitieren
APA
Echterhof, A., Dharmaraj, T., Blankenberg, P., Targ, B., Nguyen, T. D., Bollyky, P. L., Smith, N. M., & Blankenberg, F. G. (2026). Whole-body distribution of three Pseudomonas phages characterized by a translational physiologically based pharmacokinetic model. Antimicrobial Agents and Chemotherapy. https://doi.org/10.1128/aac.01506-25
Vancouver
Echterhof A, Dharmaraj T, Blankenberg P, Targ B, Nguyen TD, Bollyky PL, et al. Whole-body distribution of three Pseudomonas phages characterized by a translational physiologically based pharmacokinetic model. Antimicrobial Agents and Chemotherapy. 2026. doi:10.1128/aac.01506-25
BibTeX
@article{Echterhof2026,
author = {Echterhof, Arne and Dharmaraj, Tejas and Blankenberg, Patrick and Targ, Bobby and Nguyen, Thomas D and Bollyky, Paul L and Smith, Nicholas M and Blankenberg, Francis G},
title = {Whole-body distribution of three Pseudomonas phages characterized by a translational physiologically based pharmacokinetic model},
journal = {Antimicrobial Agents and Chemotherapy},
year = {2026},
doi = {10.1128/aac.01506-25}
}
EUVIMED